These increases were reduced by Syn treatment, suggesting that Syn reduced liver damage in the AIH mouse model by downregulating the expression of the NLRP3 inflammasome, signaling pathway components to inhibit pyroptosis. Here, NLRP3 is linked to autoimmune hepatitis.